Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Stefan Andreas. (2020) Effects of LAMA/LABA Alone and in Combination on Cardiac Safety. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1931-1933.
Read now
Read now
Stefan Andreas, Ulrich Bothner, Alberto de la Hoz, Isabel Kloer, Matthias Trampisch & Peter Alter. (2020) No Influence on Cardiac Arrhythmia or Heart Rate from Long-Term Treatment with Tiotropium/Olodaterol versus Monocomponents by Holter ECG Analysis in Patients with Moderate-to-Very-Severe COPD. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1945-1953.
Read now
Read now
Jens Ellingsen, Gunnar Johansson, Kjell Larsson, Karin Lisspers, Andrei Malinovschi, Björn Ställberg, Marcus Thuresson & Christer Janson. (2020) Impact of Comorbidities and Commonly Used Drugs on Mortality in COPD – Real-World Data from a Primary Care Setting. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 235-245.
Read now
Read now
Craig LaForce, Eric Derom, Ulrich Bothner, Isabel M Kloer, Matthias Trampisch & Roland Buhl. (2018) Long-term safety of tiotropium/olodaterol Respimat® in patients with moderate-to-very severe COPD and renal impairment in the TONADO® studies. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1819-1831.
Read now
Read now
Kirill A Zykov & Svetlana I Ovcharenko. (2017) Approaches to drug therapy for COPD in Russia: a proposed therapeutic algorithm. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 1125-1133.
Read now
Read now
Nicola A Hanania, Suzanne C. Lareau & Barbara P. Yawn. (2017) Safety of inhaled long-acting anti-muscarinic agents in COPD. Postgraduate Medicine 129:5, pages 500-512.
Read now
Read now
Ching Kuo Tan, Gui Quan Say & James B Geake. (2016) Long-term safety of tiotropium delivered by Respimat® SoftMist™ Inhaler: patient selection and special considerations. Therapeutics and Clinical Risk Management 12, pages 1433-1444.
Read now
Read now
Eric Derom, Guy G Brusselle & Guy F Joos. (2016) Efficacy of tiotropium–olodaterol fixed-dose combination in COPD. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 3163-3177.
Read now
Read now
Pinar Yildiz, Mesut Bayraktaroglu, Didem Gorgun & Funda Secik. (2016) Bronchodilator efficacy of 18 μg once-daily tiotropium inhalation via Discair® versus HandiHaler® in adults with chronic obstructive pulmonary disease: randomized, active-controlled, parallel-group, open-label, Phase IV trial. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 2859-2867.
Read now
Read now
Andrea S Melani. (2015) Long-acting muscarinic antagonists. Expert Review of Clinical Pharmacology 8:4, pages 479-501.
Read now
Read now
Articles from other publishers (4)
A. M. Chaulin & D. V. Duplyakov. (2021) Comorbidity in chronic obstructive pulmonary disease and cardiovascular disease. Cardiovascular Therapy and Prevention 20:3, pages 2539.
Crossref
Crossref
Aleksey Mikhailovich Chaulin, Julia Vladimirovna Grigoryeva & Dmitriy Viktorovich Duplyakov. (2020) COMBORIDITY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND CARDIOVASCULAR DISEASES: GENERAL FACTORS, PATHOPHYSIOLOGICAL MECHANISMS AND CLINICAL SIGNIFICANCE. Journal of Clinical Practice.
Crossref
Crossref
Mario Cazzola, Luigino Calzetta, Barbara Rinaldi, Clive Page, Giuseppe Rosano, Paola Rogliani & Maria Gabriella Matera. (2017) Management of Chronic Obstructive Pulmonary Disease in Patients with Cardiovascular Diseases. Drugs 77:7, pages 721-732.
Crossref
Crossref
Maria Gabriella Matera & Mario Cazzola. 2017. Pharmacology and Therapeutics of Asthma and COPD. Pharmacology and Therapeutics of Asthma and COPD
41
62
.